COJYXRGJZGWOKB-UHFFFAOYSA-N
C31H34F4N6O2 — CID 138542231
Data last refreshed: (MolForge compound catalog, from PubChem)
About COJYXRGJZGWOKB-UHFFFAOYSA-N
COJYXRGJZGWOKB-UHFFFAOYSA-N (PubChem CID 138542231) has the molecular formula C31H34F4N6O2 and a molecular weight of 598.65 g/mol. Its IUPAC name is N-[4-fluoro-5-[1-(pyridin-3-ylmethyl)-3,6-dihydro-2H-pyridin-4-yl]-2-(3,4,5-trimethylpiperazin-1-yl)phenyl]-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carboxamide.
Molecular Properties
| Compound Name | COJYXRGJZGWOKB-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 138542231 |
| Molecular Formula | C31H34F4N6O2 |
| Molecular Weight | 598.65 g/mol |
| Exact Mass | 598.27 |
| IUPAC Name | N-[4-fluoro-5-[1-(pyridin-3-ylmethyl)-3,6-dihydro-2H-pyridin-4-yl]-2-(3,4,5-trimethylpiperazin-1-yl)phenyl]-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carboxamide |
| SMILES | CC1CN(c2cc(F)c(C3=CCN(Cc4cccnc4)CC3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC(C)N1C |
| InChI | InChI=1S/C31H34F4N6O2/c1-19-16-41(17-20(2)39(19)3)28-13-26(32)23(22-6-9-40(10-7-22)18-21-5-4-8-36-14-21)11-27(28)38-30(43)24-15-37-29(42)12-25(24)31(33,34)35/h4-6,8,11-15,19-20H,7,9-10,16-18H2,1-3H3,(H,37,42)(H,38,43) |
| InChIKey | COJYXRGJZGWOKB-UHFFFAOYSA-N |
| XLogP | 5.00 |
| TPSA | 84.57 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 598.65 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138542231 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.